Sangamo Therapeutics, Inc

LPL Financial LLC SGMO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/11/2026

Shares

34,009

Value ($000)

14

Weight

0.0%

2014 Q1 - 2025 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/11/2026	14	0.0%	34,009	12/31/2025
2025 Q3	11/12/2025	24	0.0%	35,099	9/30/2025
2025 Q2	8/12/2025	19	0.0%	35,099	6/30/2025
2025 Q1	5/7/2025	18	0.0%	27,429	3/31/2025
2024 Q4	2/11/2025	32	0.0%	31,031	12/31/2024
2024 Q3	11/8/2024	13	0.0%	14,533	9/30/2024
2024 Q2	8/7/2024	5	0.0%	14,533	6/30/2024
2024 Q1	5/10/2024	8	0.0%	11,334	3/31/2024
2022 Q3	11/14/2022	52	0.0%	10,671	9/30/2022
2021 Q4	2/14/2022	86	0.0%	11,498	12/31/2021
2021 Q3	11/15/2021	116	0.0%	12,893	9/30/2021
2021 Q2	8/13/2021	180	0.0%	15,025	6/30/2021
2021 Q1	5/14/2021	151	0.0%	12,068	3/31/2021
2020 Q4	2/12/2021	315	0.0%	20,215	12/31/2020
2020 Q3	11/9/2020	212	0.0%	22,405	9/30/2020
2020 Q2	8/13/2020	125	0.0%	13,906	6/30/2020
2020 Q1	5/14/2020	76	0.0%	12,006	3/31/2020
2019 Q4	2/14/2020	92	0.0%	10,975	12/31/2019
2014 Q1	5/12/2014	189	0.0%	10,461	3/31/2014